- Filed
- Apr 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 20, 2025 | 25.89M sh |
| Capex | FY 2024 · Dec 31, 2024 | $331K |
| Capex | FY 2024 · Dec 31, 2023 | $221K |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 19.53M sh |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | −$1.22M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $921K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $10.14M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $13.52M |
| Current Assets | FY 2024 · Dec 31, 2023 | $13.02M |
| Total Assets | FY 2024 · Dec 31, 2023 | $17.25M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.01 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.01 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $3M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $200K |
| Net Income | FY 2024 · Dec 31, 2023 | −$235K |
| Operating Income | FY 2024 · Dec 31, 2023 | −$399K |
| Gross Profit | FY 2024 · Dec 31, 2023 | $3.26M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $14.55M |
| Revenue | FY 2024 · Dec 31, 2023 | $17.8M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $2.75M |